The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer

BACKGROUND: Breast cancer is a highly heterogeneous disease. Early-stage, non-metastatic breast cancer is considered curable after definitive treatment. Early detection of tumor recurrence and metastasis through sensitive biomarkers is helpful for guiding clinical decision-making and early intervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Zhang, Jie, Li, Jiao-Yang, Xu, Lu, Wang, Si-Ning, Zhang, Jun-Qi, Xun, Zhou, Xia, Yu, Cao, Jian-Bo, Liu, Yang, Shi, Li-Yan, Li, Wei, Shi, Yong-Lei, He, Yuan-Ge, Gu, De-Jian, Yu, Zheng-Yuan, Chen, Kai, Lan, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840987/
https://www.ncbi.nlm.nih.gov/pubmed/36654951
http://dx.doi.org/10.21037/gs-22-634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840987/
https://www.ncbi.nlm.nih.gov/pubmed/36654951
http://dx.doi.org/10.21037/gs-22-634

Ejemplares similares